(Date:12/14/2009)... -- Dyadic International, Inc. (Pink Sheets: DYAI) ("Dyadic") ... with The Scripps Research Institute ("Scripps") by entering ... genome of Dyadic,s patented and proprietary C1 fungus ... the successful relationship between the two organizations which ... to annotate the C1 genome for the first ...
(Date:12/14/2009)... N.J., Dec. 14 The third edition ... , published by the Infusion ... treatment for anthracycline extravasation.(1) Anthracyclines are a ... and epirubicin that have been used in the ... early 1970s.(2) ,, According to the ...
(Date:12/14/2009)... -- Lionbridge (Nasdaq: LIOX ) today ... three-year master services agreement with a multi-billion ... that serve patients in approximately 100 countries. ... sole provider for translation of the company,s ... human resources, legal, and corporate communications information. ...
(Date:12/14/2009)... Decision Resources, one of the world,s ... healthcare issues, finds that, owing to the launches ... market will increase more than sevenfold from $790 ... in the United States, France, Germany, Italy, Spain, ... Pharmacor report entitled Atrial Fibrillation finds ...
Breaking Biology Technology:Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2... WHO and CDC have stated that the,predictive accuracy ... -- often correct less than 50% of the time,especially ... yet accurate in,our predictions of upcoming influenza strains, approximately ... States alone., As in the case of hurricanes, ...
... (Nasdaq: TPTX ) today announced financial results for ... period, the Company posted,revenue of $1.2 million and a ... $14.3 million at September 30, 2008., "The past ... transition to a development-only company," said Ev Graham, acting ...
... /Xinhua-PRNewswire-FirstCall/ -- China Shenghuo,Pharmaceutical Holdings, Inc. (Amex: ... which is engaged in the research, development, ... cosmetic products,in the People,s Republic of China, ... (formerly the American Stock Exchange) (the "Exchange") ...
Other Biology Technology:A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks 2A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks 3TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 2TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 3TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 4TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 5TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 6TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 7NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing 2NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing 3NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing 4... leading study that has implications for the development of ... ovarian cancers that have lost the expression of a ... the loss of the GPC3 gene induces overgrowth through ... cancer growth. , Published today in Developmental Cell, the ...
... May 12, 2008 There exists much ethical controversy brought ... to religion. In a new essay in The Journal of ... medical ethics that draws upon Jewish texts, traditions, and philosophy ... of this faith tradition. , Genetic explanations for how ...
... new project (RevGenUK) is being launched at the John Innes ... , This knowledge can be used to improve the ... grow more sustainably with reduced nitrogen fertilisers. , ... and Biological Sciences Research Council (BBSRC), the project builds on ...
Other Biology News:Religion and the narrative of biological science 2... These handy dispensers save space and ... and other garb. They are the ... parts used in labs, processing and ... charges and the particles they attract. ...
... 2 NaO 7 S 2 Formula Weight: ... Identity: By IR epsilon max (615 nm, ... equal to 60 x 10 3 Loss ... lambda max (H 2 O solution): ...
...
... FP-6500 is the research-grade spectrofluorometer with a ... sensitivity S/N ratio 200 or greater for ... is especially designed to keep in mind ... as kinetics, stopped-flow, titration, or anisotropic measurements. ...
Biology Products:Biology NavigationMedical Navigation